Total Payments
$1,295
2024 Payments
$491.13
Companies
17
Transactions
59
Medicare Patients
581
Medicare Billing
$44,722
Payment Breakdown by Category
Food & Beverage$1,194 (92.2%)
Education$101.15 (7.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,194 | 56 | 92.2% |
| Education | $101.15 | 3 | 7.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $230.45 | 10 | $0 (2024) |
| Merck Sharp & Dohme LLC | $202.19 | 10 | $0 (2024) |
| Amgen Inc. | $160.68 | 6 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $95.88 | 5 | $0 (2021) |
| Astellas Pharma US Inc | $94.99 | 1 | $0 (2024) |
| Lilly USA, LLC | $88.42 | 4 | $0 (2022) |
| Dynavax Technologies Corporation | $85.80 | 5 | $0 (2024) |
| SCILEX PHARMACEUTICALS INC. | $64.56 | 3 | $0 (2024) |
| Novo Nordisk Inc | $60.21 | 3 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $40.66 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $491.13 | 22 | Astellas Pharma US Inc ($94.99) |
| 2023 | $181.05 | 8 | PFIZER INC. ($119.70) |
| 2022 | $141.65 | 7 | Merck Sharp & Dohme LLC ($53.84) |
| 2021 | $481.47 | 22 | Amgen Inc. ($135.36) |
All Payment Transactions
59 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $26.76 | General |
| Category: Hepatitis B Vaccine | ||||||
| 12/13/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: Bone Health | ||||||
| 11/09/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Diabetes | ||||||
| 09/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $24.52 | General |
| 08/08/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, GARDASIL 9 | Food and Beverage | In-kind items and services | $29.83 | General |
| Category: VACCINE | ||||||
| 07/12/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: Analgesic | ||||||
| 06/03/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $26.39 | General |
| 06/03/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 06/03/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 05/13/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $2.17 | General |
| Category: Hepatitis B Vaccine | ||||||
| 05/12/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: Hepatitis B Vaccine | ||||||
| 04/25/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, GARDASIL 9 | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: VACCINE | ||||||
| 04/19/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/26/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $94.99 | General |
| 03/08/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Analgesic | ||||||
| 02/29/2024 | Cranial Technologies, Inc | Doc Band (Device) | Food and Beverage | Cash or cash equivalent | $16.06 | General |
| Category: Cranial Orthotic | ||||||
| 02/16/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: Hepatitis B Vaccine | ||||||
| 02/16/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: Hepatitis B Vaccine | ||||||
| 01/23/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/13/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: Analgesic | ||||||
| 01/11/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, GARDASIL 9 | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: VACCINE | ||||||
| 11/27/2023 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/16/2023 | Merck Sharp & Dohme LLC | M-M-R II (Biological), VAXNEUVANCE, GARDASIL 9 | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: VACCINE | ||||||
| 10/20/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $26.01 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 210 | 220 | $46,280 | $18,007 |
| 2022 | 6 | 122 | 147 | $26,624 | $8,953 |
| 2021 | 8 | 209 | 256 | $40,418 | $14,886 |
| 2020 | 3 | 40 | 42 | $9,319 | $2,876 |
Total Patients
581
Total Services
665
Medicare Billing
$44,722
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 42 | 46 | $10,525 | $4,062 | 38.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 26 | 26 | $10,076 | $3,459 | 34.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 12 | 12 | $5,760 | $3,395 | 58.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 50 | 56 | $9,128 | $2,740 | 30.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 33 | 33 | $6,204 | $2,343 | 37.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 13 | 13 | $2,445 | $935.09 | 38.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 19 | 19 | $1,197 | $600.02 | 50.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 15 | 15 | $945.00 | $473.70 | 50.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 49 | 72 | $11,736 | $3,502 | 29.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 18 | 18 | $6,450 | $2,395 | 37.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 19 | 20 | $4,500 | $1,375 | 30.6% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 14 | 14 | $2,632 | $1,087 | 41.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 11 | 12 | $756.00 | $374.22 | 49.5% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 11 | 11 | $550.00 | $220.29 | 40.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 68 | 111 | $18,093 | $6,152 | 34.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 33 | 33 | $11,813 | $4,470 | 37.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 21 | 25 | $5,545 | $2,033 | 36.7% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 12 | 12 | $900.00 | $778.84 | 86.5% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2021 | 31 | 31 | $1,550 | $620.00 | 40.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 15 | 15 | $690.00 | $300.00 | 43.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 15 | 15 | $945.00 | $273.57 | 28.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 14 | 14 | $882.00 | $258.02 | 29.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 12 | 12 | $3,738 | $1,438 | 38.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 11 | 12 | $2,685 | $761.44 | 28.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 17 | 18 | $2,896 | $676.93 | 23.4% |
About Jennifer Tran, FNP
Jennifer Tran, FNP is a Primary Care healthcare provider based in Daly City, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/26/2016. The National Provider Identifier (NPI) number assigned to this provider is 1689031346.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jennifer Tran, FNP has received a total of $1,295 in payments from pharmaceutical and medical device companies, with $491.13 received in 2024. These payments were reported across 59 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,194).
As a Medicare-enrolled provider, Tran has provided services to 581 Medicare beneficiaries, totaling 665 services with total Medicare billing of $44,722. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Primary Care
- Other Specialties Family, Nurse Practitioner
- Location Daly City, CA
- Active Since 01/26/2016
- Last Updated 12/11/2025
- Taxonomy Code 363LP2300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1689031346
Products in Payments
- EVENITY (Biological) $136.40
- FARXIGA (Drug) $95.88
- PREVNAR 13 (Biological) $94.97
- Heplisav-B (Drug) $85.80
- GARDASIL 9 (Biological) $71.50
- GARDASIL (Biological) $69.34
- ELIQUIS (Drug) $67.06
- ZTLido (Drug) $64.56
- JARDIANCE (Drug) $57.91
- TRULICITY (Drug) $42.78
- PAXLOVID (Drug) $42.41
- XARELTO (Drug) $40.66
- ROTATEQ (Biological) $39.20
- MOUNJARO (Drug) $27.57
- PREVNAR 20 (Biological) $26.01
- Repatha (Biological) $24.28
- Quzyttir (Drug) $23.45
- M-M-R II (Biological) $22.15
- Kerendia (Drug) $21.40
- Crysvita (Drug) $19.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.